337 related articles for article (PubMed ID: 25797568)
21. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
22. Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.
Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
Eur J Surg Oncol; 2015 Mar; 41(3):282-94. PubMed ID: 25491892
[TBL] [Abstract][Full Text] [Related]
23. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.
Stahl M; Walz MK; Riera-Knorrenschild J; Stuschke M; Sandermann A; Bitzer M; Wilke H; Budach W
Eur J Cancer; 2017 Aug; 81():183-190. PubMed ID: 28628843
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
[TBL] [Abstract][Full Text] [Related]
25. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
[TBL] [Abstract][Full Text] [Related]
26. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
27. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
Davidson M; Chau I
Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
McNamara MJ; Adelstein DJ; Bodmann JW; Greskovich JF; Ives DI; Mason DP; Murthy SC; Rice TW; Saxton JP; Sohal D; Stephans K; Rodriguez CP; Videtic GM; Rybicki LA
J Thorac Oncol; 2014 Oct; 9(10):1561-7. PubMed ID: 25170643
[TBL] [Abstract][Full Text] [Related]
29. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
30. Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study.
Stiekema J; Trip AK; Jansen EP; Aarts MJ; Boot H; Cats A; Ponz OB; Gradowska PL; Verheij M; van Sandick JW
Ann Surg Oncol; 2015 Feb; 22(2):581-8. PubMed ID: 25164039
[TBL] [Abstract][Full Text] [Related]
31. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.
Lowenfeld L; Datta J; Lewis RS; McMillan MT; Mamtani R; Damjanov N; Chandrasekhara V; Karakousis GC; Drebin JA; Fraker DL; Roses RE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S863-72. PubMed ID: 26100818
[TBL] [Abstract][Full Text] [Related]
32. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
33. Multimodality treatment for localized gastro-oesophageal cancer.
Okines AF; Cunningham D
Ann Oncol; 2010 Oct; 21 Suppl 7():vii286-93. PubMed ID: 20943630
[TBL] [Abstract][Full Text] [Related]
34. Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
Lagergren J; Andersson G; Talbäck M; Drefahl S; Bihagen E; Härkönen J; Feychting M; Ljung R
Cancer; 2016 Jan; 122(2):207-12. PubMed ID: 26447737
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of carcinomas of the oesophagogastric junction - results achieved in multicentre studies].
Steinert R; Gastinger I; Ridwelski K; Ptok H; Wolff S; Meyer F; Otto R; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):403-9. PubMed ID: 23950077
[TBL] [Abstract][Full Text] [Related]
36. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
Dikken JL; Lemmens VE; Wouters MW; Wijnhoven BP; Siersema PD; Nieuwenhuijzen GA; van Sandick JW; Cats A; Verheij M; Coebergh JW; van de Velde CJ
Eur J Cancer; 2012 Jul; 48(11):1624-32. PubMed ID: 22317953
[TBL] [Abstract][Full Text] [Related]
37. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
38. Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction.
Stewart CJ; Hillery S
J Clin Pathol; 2007 Nov; 60(11):1284-9. PubMed ID: 17893119
[TBL] [Abstract][Full Text] [Related]
39. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study.
Mokadem I; Dijksterhuis WPM; van Putten M; Heuthorst L; de Vos-Geelen JM; Haj Mohammad N; Nieuwenhuijzen GAP; van Laarhoven HWM; Verhoeven RHA
Gastric Cancer; 2019 Nov; 22(6):1263-1273. PubMed ID: 30949777
[TBL] [Abstract][Full Text] [Related]
40. Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.
Franco P; Arcadipane F; Strignano P; Spadi R; Trino E; Martini S; Iorio GC; Satolli MA; Airoldi M; Romagnoli R; Camandona M; Ricardi U
Med Oncol; 2017 Mar; 34(3):40. PubMed ID: 28176241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
